Free Trial
NASDAQ:ASTC

Astrotech 2/14/2025 Earnings Report

Astrotech logo
$4.95 -0.05 (-1.00%)
Closing price 10/9/2025 03:59 PM Eastern
Extended Trading
$4.94 0.00 (-0.10%)
As of 10/9/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Astrotech EPS Results

Actual EPS
-$2.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Astrotech Revenue Results

Actual Revenue
$260.00 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Astrotech Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Astrotech's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Conference Call Resources

Astrotech Earnings Headlines

Astrotech Reports Fiscal Year 2025 Financial Results
Trump to get REVENGE on the banks??
Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network — and one $3 asset, with nine ETFs already in the works, may skyrocket if his plan moves forward.tc pixel
Astrotech appoints Nihanth Badugu as COO
Astrotech Appoints Nihanth Badugu as New COO
See More Astrotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Astrotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Astrotech and other key companies, straight to your email.

About Astrotech

Astrotech (NASDAQ:ASTC) Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms. A key milestone was the spin-out of 908 Devices in 2020, a subsidiary that developed portable mass spectrometers for field detection of chemicals and bio-agents. Building on that foundation, Astrotech continues to pursue point-of-care screening technologies for environmental monitoring, food safety and clinical diagnostics.

Through Astrotech Solar and other affiliates, the company is also active in renewable energy commercialization. This segment concentrates on high-efficiency photovoltaic materials and manufacturing processes originally developed in partnership with academic and federal laboratories. By licensing proprietary cell architectures and overseeing pilot-scale production, Astrotech aims to reduce costs and accelerate adoption of clean-energy solutions in global markets.

Founded in 1984 as AIT International, Astrotech has evolved via strategic acquisitions and spin-offs to maintain a diversified technology portfolio. The company collaborates with public-sector agencies, research institutions and industry partners to advance its product pipeline. Astrotech’s leadership brings expertise in engineering, regulatory affairs and business development to guide the firm’s long-term growth and commercialization efforts.

View Astrotech Profile

More Earnings Resources from MarketBeat